Assessing Eye Health and Eye Care Needs Among North American Native Individuals.
Journal
JAMA ophthalmology
ISSN: 2168-6173
Titre abrégé: JAMA Ophthalmol
Pays: United States
ID NLM: 101589539
Informations de publication
Date de publication:
01 Feb 2022
01 Feb 2022
Historique:
pubmed:
24
12
2021
medline:
21
4
2022
entrez:
23
12
2021
Statut:
ppublish
Résumé
There are few population-level studies on ophthalmic conditions and services among North American Native individuals. To evaluate whether disparities in ophthalmic conditions and services exist between North American Native individuals and non-Hispanic White individuals in the US. This cross-sectional study used 100% Medicare fee-for-service (MFFS) enrollment data from the Vision and Eye Health Surveillance System (VEHSS) to examine ophthalmic conditions and service use in North American Native individuals and non-Hispanic White individuals in the US. In this study North American Native individuals included those who identified as American Indian, Native Alaskan, Native Hawaiian, and Pacific Islander. Data were analyzed from August 2020 to April 2021. Claims and sociodemographic characteristics were extracted and means computed for categories of ophthalmic conditions and select ophthalmic services. Ophthalmic conditions and services were defined in the VEHSS using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Clinical Modification (ICD-10-CM) codes. Logistic regression was used to model differences between age-adjusted mean ophthalmic condition and service claim rates among North American Native individuals and non-Hispanic White individuals for each age cohort. Matching ophthalmic condition claim rates and ophthalmic service claim rates was performed to examine disparities by racial group. Mean age-adjusted claim rates for ophthalmic conditions and services among North American Native individuals vs non-Hispanic White individuals per 100 persons. Claims were identified for 177 100 Native American Native individuals and 24 438 000 non-Hispanic White individuals. In 16 of 17 ophthalmic condition categories and 6 of 9 service categories, North American Native individuals had significantly different claim rates from non-Hispanic White individuals. There were higher ophthalmic condition claim rates but lower service claim rates for North American Native individuals (vs non-Hispanic White individuals) for refractive errors (ophthalmic condition, 17.2 vs 11.1; service, 48.3 vs 49.6, respectively; P < .001); blindness and low vision (ophthalmic condition, 1.48 vs 0.75: service, 19.2 vs 20.1, respectively; P < .001); injury, burns, and surgical complications (ophthalmic condition, 1.8 vs 1.7; service, 19.2 vs 20.1, respectively; P < .001); and orbital and external disease (ophthalmic condition, 15.7 vs 13.3; service, 48.3 vs 49.6, respectively; P < .001). For diabetic eye diseases, North American Native individuals had higher ophthalmic condition claim rates (5.22 vs 2.20) but no difference in service claim rates (14.4 vs 14.8; P = .26) compared with non-Hispanic White individuals. In this cross-sectional study, North American Native individuals had higher prevalence of ophthalmic conditions but no corresponding increase in services (treatment for most ophthalmic conditions) compared with non-Hispanic White individuals. These results suggest worse eye health and higher unmet eyecare needs for North American Native individuals with MFFS coverage compared with non-Hispanic White individuals with MFFS coverage.
Identifiants
pubmed: 34940785
pii: 2787498
doi: 10.1001/jamaophthalmol.2021.5507
pmc: PMC8855236
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
134-142Subventions
Organisme : NEI NIH HHS
ID : R01 EY031033
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY031337
Pays : United States
Références
Arch Ophthalmol. 1985 Feb;103(2):208-12
pubmed: 3883967
MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1020-1023
pubmed: 31725705
Eye (Lond). 2007 Apr;21(4):528-33
pubmed: 16456592
Med Care. 2020 Nov;58(11):981-987
pubmed: 32947510
J Med Syst. 2016 Jun;40(6):145
pubmed: 27118011
Diabetes Care. 1997 May;20(5):757-9
pubmed: 9135938
Eye Rep. 2019;5(1):9-14
pubmed: 31559003
Arch Ophthalmol. 2005 Dec;123(12):1699-704
pubmed: 16344442
Am J Public Health. 2006 Dec;96(12):2122-34
pubmed: 17077399
JAMA Intern Med. 2016 Jun 1;176(6):858-60
pubmed: 27182901
J Am Optom Assoc. 1997 Jul;68(7):425-31
pubmed: 9248249
J Gen Intern Med. 2011 May;26(5):480-6
pubmed: 21132462
Am J Public Health. 2005 Nov;95(11):1940-2
pubmed: 16195516
Ophthalmology. 2011 Jul;118(7):1380-5
pubmed: 21310490
Am J Public Health. 2005 May;95(5):881-6
pubmed: 15855469
Can J Ophthalmol. 2017 Nov;52 Suppl 1:S19-S29
pubmed: 29074008
J Glaucoma. 2021 May 1;30(5):402-409
pubmed: 33273279
Am J Ophthalmol. 1970 Dec;70(6):981-3
pubmed: 5490627
Am J Hum Biol. 1993;5(4):399-413
pubmed: 28548395
Diabetes Care. 1993 Jan;16(1):253-6
pubmed: 8422786
Ophthalmic Epidemiol. 2009 May-Jun;16(3):163-74
pubmed: 19437311
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
ARC J Diabetes Endocrinol. 2017;3(1):34-41
pubmed: 30637353
Curr Diab Rep. 2013 Dec;13(6):814-23
pubmed: 24037313
PLoS One. 2018 Jun 20;13(6):e0198551
pubmed: 29924846
Acta Ophthalmol (Copenh). 1991 Feb;69(1):27-32
pubmed: 2028765
Telemed J E Health. 2013 Dec;19(12):942-8
pubmed: 24102102